ID

19648

Descripción

Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00897208

Link

https://clinicaltrials.gov/show/NCT00897208

Palabras clave

Versiones (1)
  1. 18/1/17 18/1/17 -
Subido en

18 de enero de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00897208

Inglés

Eligibility Breast Cancer NCT00897208

1 formularios  
Criteria
Descripción

Criteria

meets 1 of the following criteria:
Descripción

criteria Fulfill

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1550543
newly diagnosed (within 30 calendar days of diagnosis) stage i or ii breast cancer
Descripción

Breast Carcinoma TNM clinical staging

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C3258246
node-negative or node-positive disease
Descripción

Disease Negative Lymph Node | Disease lymph node positive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0678034
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0746319
newly diagnosed ductal carcinoma in situ (stage 0) of the breast
Descripción

Noninfiltrating Intraductal Carcinoma TNM clinical staging

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0007124
UMLS CUI [1,2]
C3258246
at high risk of developing breast cancer, as indicated by at least 1 of the following criteria:
Descripción

At high risk for breast cancer

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4047809
gail model 5-year risk score ≥ 1.66%
Descripción

Risk Percentage Year Quantity Gail Risk Model

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0035647
UMLS CUI [1,2]
C0439165
UMLS CUI [1,3]
C0439234
UMLS CUI [1,4]
C1265611
UMLS CUI [1,5]
C1511297
gail model lifetime-risk estimate ≥ 20%
Descripción

Lifetime Risk Percentage Gail Risk Model

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1517878
UMLS CUI [1,2]
C0439165
UMLS CUI [1,3]
C1511297
known deleterious brca 1 or 2 gene mutation carrier
Descripción

BRCA1 Mutation Carrier Deleterious | BRCA2 Mutation Carrier Deleterious

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3899965
UMLS CUI [1,2]
C2985436
UMLS CUI [2,1]
C3899964
UMLS CUI [2,2]
C2985436
history of lobular carcinoma in situ or atypical ductal or lobular hyperplasia
Descripción

Non-infiltrating lobular carcinoma | Atypical ductal hyperplasia | Atypical lobular hyperplasia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0334381
UMLS CUI [2]
C0442834
UMLS CUI [3]
C0442835
at low or average risk of developing breast cancer (control group)
Descripción

Breast Carcinoma Low Risk | Breast Carcinoma Risk Average

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C3538919
UMLS CUI [2,1]
C0678222
UMLS CUI [2,2]
C0035647
UMLS CUI [2,3]
C1510992
gail model 5-year risk score < 1.66% or lifetime risk < 20%
Descripción

Risk Percentage Year Quantity Gail Risk Model | Lifetime Risk Percentage Gail Risk Model

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0035647
UMLS CUI [1,2]
C0439165
UMLS CUI [1,3]
C0439234
UMLS CUI [1,4]
C1265611
UMLS CUI [1,5]
C1511297
UMLS CUI [2,1]
C1517878
UMLS CUI [2,2]
C0439165
UMLS CUI [2,3]
C1511297
no advanced breast cancer
Descripción

Advanced breast cancer

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3495917
hormone receptor status not specified
Descripción

Hormone Receptor Status Unspecified

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019929
UMLS CUI [1,2]
C0449438
UMLS CUI [1,3]
C0205370
patient characteristics:
Descripción

Client Characteristics

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0815172
pre- or post-menopausal
Descripción

Premenopausal state | Postmenopausal state

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232969
UMLS CUI [2]
C0232970
prior concurrent therapy:
Descripción

Therapeutic procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0087111
no prior chemotherapy for breast cancer or any other cancer
Descripción

Chemotherapy Breast Carcinoma | Chemotherapy Malignant Neoplasms

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0678222
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C0006826
more than 3 months since prior and no concurrent estrogen or other hormones
Descripción

Estrogen hormone therapy | Hormone Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0474186
UMLS CUI [2]
C0279025
more than 3 months since prior oral contraceptives
Descripción

Contraceptives, Oral

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009905
no concurrent selective estrogen receptor modulators (tamoxifen citrate or raloxifene)
Descripción

Selective Estrogen Receptor Modulators | Tamoxifen Citrate | Raloxifene

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0732611
UMLS CUI [2]
C0079589
UMLS CUI [3]
C0244404
no concurrent aromatase inhibitors
Descripción

Aromatase Inhibitors

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0593802
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT00897208

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
criteria Fulfill
Item
meets 1 of the following criteria:
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Breast Carcinoma TNM clinical staging
Item
newly diagnosed (within 30 calendar days of diagnosis) stage i or ii breast cancer
boolean
C0678222 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Disease Negative Lymph Node | Disease lymph node positive
Item
node-negative or node-positive disease
boolean
C0012634 (UMLS CUI [1,1])
C0678034 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0746319 (UMLS CUI [2,2])
Noninfiltrating Intraductal Carcinoma TNM clinical staging
Item
newly diagnosed ductal carcinoma in situ (stage 0) of the breast
boolean
C0007124 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
At high risk for breast cancer
Item
at high risk of developing breast cancer, as indicated by at least 1 of the following criteria:
boolean
C4047809 (UMLS CUI [1])
Risk Percentage Year Quantity Gail Risk Model
Item
gail model 5-year risk score ≥ 1.66%
boolean
C0035647 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0439234 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
C1511297 (UMLS CUI [1,5])
Lifetime Risk Percentage Gail Risk Model
Item
gail model lifetime-risk estimate ≥ 20%
boolean
C1517878 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C1511297 (UMLS CUI [1,3])
BRCA1 Mutation Carrier Deleterious | BRCA2 Mutation Carrier Deleterious
Item
known deleterious brca 1 or 2 gene mutation carrier
boolean
C3899965 (UMLS CUI [1,1])
C2985436 (UMLS CUI [1,2])
C3899964 (UMLS CUI [2,1])
C2985436 (UMLS CUI [2,2])
Non-infiltrating lobular carcinoma | Atypical ductal hyperplasia | Atypical lobular hyperplasia
Item
history of lobular carcinoma in situ or atypical ductal or lobular hyperplasia
boolean
C0334381 (UMLS CUI [1])
C0442834 (UMLS CUI [2])
C0442835 (UMLS CUI [3])
Breast Carcinoma Low Risk | Breast Carcinoma Risk Average
Item
at low or average risk of developing breast cancer (control group)
boolean
C0678222 (UMLS CUI [1,1])
C3538919 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2,1])
C0035647 (UMLS CUI [2,2])
C1510992 (UMLS CUI [2,3])
Risk Percentage Year Quantity Gail Risk Model | Lifetime Risk Percentage Gail Risk Model
Item
gail model 5-year risk score < 1.66% or lifetime risk < 20%
boolean
C0035647 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0439234 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
C1511297 (UMLS CUI [1,5])
C1517878 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C1511297 (UMLS CUI [2,3])
Advanced breast cancer
Item
no advanced breast cancer
boolean
C3495917 (UMLS CUI [1])
Hormone Receptor Status Unspecified
Item
hormone receptor status not specified
boolean
C0019929 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
C0205370 (UMLS CUI [1,3])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Premenopausal state | Postmenopausal state
Item
pre- or post-menopausal
boolean
C0232969 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Chemotherapy Breast Carcinoma | Chemotherapy Malignant Neoplasms
Item
no prior chemotherapy for breast cancer or any other cancer
boolean
C0392920 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
Estrogen hormone therapy | Hormone Therapy
Item
more than 3 months since prior and no concurrent estrogen or other hormones
boolean
C0474186 (UMLS CUI [1])
C0279025 (UMLS CUI [2])
Contraceptives, Oral
Item
more than 3 months since prior oral contraceptives
boolean
C0009905 (UMLS CUI [1])
Selective Estrogen Receptor Modulators | Tamoxifen Citrate | Raloxifene
Item
no concurrent selective estrogen receptor modulators (tamoxifen citrate or raloxifene)
boolean
C0732611 (UMLS CUI [1])
C0079589 (UMLS CUI [2])
C0244404 (UMLS CUI [3])
Aromatase Inhibitors
Item
no concurrent aromatase inhibitors
boolean
C0593802 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial